Neurocrine Biosciences | DEBITO



Debt Cambiamento Data
AbbVie USD 69.89B 2.74B 2025-03
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
ALKERMES USD 72.68M 72.68M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Cytokinetics USD 658.13M 1.01M 2025-03
Dynavax Technologies USD 260.51M 36.65M 2025-03
Exelixis USD 179.84M 179.84M 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
Halozyme Therapeutics USD 1.51B 1.65M 2025-06
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Pfizer USD 60.93B 1.18B 2025-06
Prothena USD 9.78M 9.78M 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Repligen USD 533.72M 149.97M 2025-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Teva Pharmaceutical Industries USD 17.52B 872M 2025-06
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Neurocrine Biosciences DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.